Mammary stem cell number as a determinate of breast cancer risk.
The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve as targets for transformation. Stem cell number may be set during critical windows of development, including in utero, adolescence, and pregnancy. The growth hormone/insulin-like growth factor-1 axis may play an important role in regulating breast stem cell number during these developmental windows, suggesting an important link between this signaling pathway and breast cancer risk.
Ginestier
Christophe
C
Wicha
Max S
MS
D001943:Breast Neoplasms / Q000453:epidemiology*; D005260:Female; D006801:Humans; D039902:Multipotent Stem Cells / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000473:pathology*; D012307:Risk Factors
Domest Anim Endocrinol. 2004 Nov;27(4):363-78
15519040
Horm Res. 2004;62 Suppl 1:108-15
15761242
Biochem Biophys Res Commun. 2005 Dec 16;338(2):1048-58
16259960
Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6
16488983
Int J Cancer. 2006 Nov 1;119(9):2007-25
16823839
Lancet. 1990 Apr 21;335(8695):939-40
1970028
Breast Cancer Res. 2007;9(3):R29
17501995
Mol Cell Endocrinol. 2002 Nov 29;197(1-2):153-65
12431808
Trends Endocrinol Metab. 2003 Jan;14(1):28-34
12475609
Genes Dev. 2003 May 15;17(10):1253-70
12756227
N Engl J Med. 2004 Oct 14;351(16):1619-26
15483280